2021 Europe Clinical Chemistry Analyzers and Reagents Market Assessment-France, Germany, Italy, Spain, UK-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 55 Tests, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

January 2021 | | ID: 21D3A42C6800EN
Venture Planning Group

Abstracts

LeadingMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the European clinical chemistry market during the next five years. The report is available by section, and can be customized to specific information needs and budget. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

This report provides a granular strategic analysis of over 55 clinical chemistry assays. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.

Rationale

The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Geographic Coverage

France, Germany, Italy, Spain, UK

Strategic Recommendations

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Market Segmentation Analysis

• Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.
• Test volume and sales forecasts for over 55 clinical chemistry assays, by country and market segment:
  • Hospitals
  • Commercial/Private Laboratories
  • Physician Offices/Group Practices
  • Ambulatory Care Centers

Individual Tests Analyzed in the Report

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid

Current and Emerging Products

• Analysis of current and emerging clinical chemistry tests.
• Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

• Assessment of current and emerging technologies, and their potential market applications.
• Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. InternalDevelopment
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Selected Tests Clinical Significance and Diagnostic Procedures
  1. Albumin
  2. Alkaline Phosphatase
  3. ALT/SGPT
  4. Ammonia
  5. Amylase
  6. AST/SGOT
  7. Bilirubin, Total
  8. Blood Gases
  9. Blood Urea Nitrogen (BUN)
  10. BNP
  11. Calcium
  12. Cardio CRP
  13. Cholesterol
  14. Cholinesterase
  15. CRP
  16. Creatinine
  17. Electrolytes
    a. Carbon Dioxide/Bicarbonate
    b. Chloride
    c. Potassium
    d. Sodium
  18. Ferritin
  19. Fructosamine
  20. Gamma-Glutamyl Transpeptidase (GGT)
  21. Glucose
  22. High Density Lipoprotein (HDL)
  23. Homocysteine
  24. hs-CRP
  25. Iron
  26. Lactate Dehydrogenase (LDH)
  27. Magnesium
  28. NT-proBNP
  29. Phosphorus
  30. Protein
  31. ST2
  32. Triglycerides
  33. Uric Acid
  34. Troponin
B. Clinical Chemistry Instrumentation Review: Operating Characteristics and Features of High-, Medium-, and Low-volume/POC analyzers
C. Major Clinical Chemistry Technologies And Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
  3. Tandem Mass Spec
  4. IT and Automation
  5. Dry Chemistry
  6. Biosensors

VII. COUNTRY ANALYSES

France, Germany, Italy, Spain, UK

VIII. COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako